There are two types of removal: Re-uptake – the neurotransmitter is reabsorbed back into the presynaptic neuron and restored inside a vesicle ready to be used again. For example, noradrenaline.
They allow the nervous system to connect to and control other systems of the body. At a chemical synapse, one neuron releases neurotransmitter molecules into a small space (the synaptic cleft) that is ...
Neurotransmitters are tiny chemical messengers that carry, boost, and balance signals between neurons (aka nerve cells) and ...
However, a series of weak stimuli can combine, increasing the amount of neurotransmitter that is released. This results in enough neurotransmitter being diffused across the synaptic cleft to ...
A fluorescent probe designed to incorporate a fluorophore into the structure of a neurotransmitter finds activity-dependent heterogeneity in dopamine release at individual synapses ...
We propose that, during secretion of neurotransmitters at synapses, the mode of exocytosis is modulated by calcium to attain optimal conditions for coupled exocytosis and endocytosis according to ...
Synapses are the connection points where neurons establish contact with each other to transmit information. For this communication to occur, the presynaptic neuron releases a neurotransmitter ...
The action potential causes the release of molecules called neurotransmitters, which pass from one end of the synapse to the other. Once these molecules cross the synapse, the chemical signal is ...
The action potential causes the release of molecules called neurotransmitters, which pass from one end of the synapse to the other. Once these molecules cross the synapse, the chemical signal is ...
The synapses between the hypothalamic supramammillary ... This plasticity is mediated by the release of the neurotransmitter glutamate, but not by the neurotransmitter GABA. Credit must be given ...
For example, disrupted ion channel or neurotransmitter receptor distribution or density play important roles in neuropathic pain, spinal cord injury, schizophrenia, myasthenia gravis, epilepsy, and ...
Despite the replacement of the monoamine hypothesis of depression with a more comprehensive understanding of multiple influencing factors in the pathology of depression, it is clear that elevating ...